DXR

Healthcare Medical Instruments & Supplies

Daxor Corporation

$10.62

-0.11 -0.98% today

Price History

Not enough data

Key Stats

Market Cap

62.00M

Avg Volume

16,717

P/E (TTM)

6.28

EPS

$1.69

52W High

$14.76

52W Low

$8.56

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

P/B Ratio

1.20

P/S Ratio

1977.10

Margins

Gross Margin 100.0%

Operating Margin (4529.9%)

Net Margin 19861.4%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

25.5%

Return on Equity

14.2%

Return on Assets

(2.6%)

Liquidity & Leverage

Current Ratio

2.88

Total Debt

About

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.